IHS Chemical Week

People & Business :: M&A

Novozymes completes acquisition of Iogen’s industrial enzyme business

12:14 AM MST | February 25, 2013 | Deepti Ramesh

Novozymes and Iogen (Ottawa, ON) say that the previously announced acquisition of Iogen Bio-Products, the industrial enzyme business of Iogen, by Novozymes has been completed. It was announced on 31 January that Novozymes would acquire Iogen Bio-Products for C$67.5 million ($66 million) and potential earn-out payments of up to C$12.5 million. The closing conditions for the transaction have been met, and the acquisition has been completed, the companies say. Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa